• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problems Mechanical Problem (1384); Infusion or Flow Problem (2964)
Patient Problems High Blood Pressure/ Hypertension (1908); Thrombosis (2100); Ventricular Tachycardia (2132); Heart Failure (2206); Hypovolemia (2243)
Event Date 11/01/2014
Event Type  Injury  
Manufacturer Narrative
Specific patient information not provided.Date of event is approximate as the data were collected between november 2014 and december 2018.Device serial numbers unknown.Author: t.Ogami, et al.¿incidence and cause of persistent low flow alarm after heartmate 3 left ventricular assist device insertion." journal of heart and lung transplantation, volume: 39, issue: 4, pages: s404.Manufacturer's investigation conclusion: a direct correlation between the heartmate 3 left ventricular assist system and the reported events (thromboembolism, hypertension, hypovolemia, right heart failure, cardiac arrhythmia, and low flow alarms) could not be conclusively determined through this investigation.A study conducted by new york-presbyterian/columbia sought to determine the incidence and cause of readmission due to persistent low flow alarms after heartmate 3 left ventricular assist device implantation.The study reviewed 135 patients who were implanted with heartmate 3 left ventricular assist devices between november 2014 and december 2018 at new york-presbyterian/columbia.Patients who required readmission due to persistent low flow alarms were identified and analyzed.A cumulative incidence function curve was constructed to analyze the probability of low flow alarm readmission.Twenty-three patients (17.4%) required 28 readmissions due to persistent low flow alarms with a median follow up of 11.2 months.The incidence of readmissions with persistent low flow alarms was 1.31 person-years.The probability of low flow alarm readmission was 17.7% at 1-year.Of the 23 patients, 4 patients (17.4%) required multiple readmissions.The etiology of the persistent low flow alarms was due to hypovolemia (39.3%), hypertension (17.8%), inflow or outflow obstruction (17.8%), right heart failure (3.6%), ventricular tachycardia (3.6%), and unknown reasons (17.8%).None of the patients had an electrical issue with the pump or a driveline disruption identified.The study concluded that readmission due to low flow alarms is relatively common after heartmate 3 left ventricular assist device implantation.Hypovolemia was the most frequent etiology of low flow alarms.Obstruction of the inflow cannula or outflow graft is a serious complication that can present with low flow alarms and requires reoperation.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) lists thromboembolism, hypertension, right heart failure, and cardiac arrhythmia as adverse events that may be associated with the use of the heartmate 3 lvas.Thromboembolism and cardiac arrhythmia are also listed as potential late postimplant complications that may be associated with the use of the heartmate 3 lvas.The ifu section 4 entitled "system monitor" explains that the low flow hazard alarm will be triggered when pump flow is less than 2.5lpm and states that changes in patient conditions can result in low flow.Section 6 entitled "patient care and management" contains information regarding the recommended anticoagulation therapy and international normalized ratio range.Section entitled 7 "alarms and troubleshooting" outlines all system alarms and the recommended actions associated with them.Additionally, the ifu states: ¿right heart failure can occur following implantation of the pump.Right ventricular dysfunction, especially when combined with elevated pulmonary vascular resistance, may limit the effectiveness of the left ventricular assist system due to reduced filling of the pump.¿ no further information was provided.The manufacturer is closing the file on this event.
 
Event Description
It was reported through the research abstract ¿incidence and cause of persistent low flow alarm after heartmate 3 left ventricular assist device insertion¿ identifying that the hm3 patients are frequently readmitted due to persistent low flow alarm.A total of 135 patients implanted with hm3 between november 2014 and december 2018 were retrospectively evaluated.The patients who required readmission due to persistent low flow alarms were identified and analyzed.Twenty-three patients (17.4%) required 28 readmissions due to persistent low flow alarms during median follow up of 11.2 months.The incidence of readmissions with persistent low flow alarms was 1.31 person-years.The probability of low flow alarm readmission was 17.7% at 1-year.Of 23 patients, 4 patients (17.4%) required multiple readmissions.The etiology of persistent low flow alarms was: hypovolemia in 11 (39.3%) and hypertension in 16 (17.8%).Inflow or outflow obstruction requiring surgical intervention was present in 5 (17.8%).The reason for the alarm was not identified in 5 patients (17.8%).No electrical pump issue or a driveline disruption was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key10978181
MDR Text Key220532555
Report Number2916596-2020-05890
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number106524US
Device Catalogue Number106524US
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/20/2020
Initial Date FDA Received12/09/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-